Stockreport

Vaxcyte Funding And Late-Stage Trials Put Valuation In Focus [Yahoo! Finance]

Vaxcyte, Inc.  (PCVX) 
PDF Vaxcyte (NasdaqGS:PCVX) has completed a major public equity offering, adding fresh capital to its balance sheet. The company is advancing its 31 valent pneumococcal c [Read more]